Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial
在一项随机试验中，印度分枝杆菌作为辅助疗法治疗II类肺结核的疗效和安全性
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-017-03514-1
Sharma, Surendra K; Katoch, Kiran; Sarin, Rohit; Balambal, Raman; Kumar Jain, Nirmal; Patel, Naresh; Murthy, Kolluri J R; Singla, Neeta; Saha, P K; Khanna, Ashwani; Singh, Urvashi; Kumar, Sanjiv; Sengupta, A; Banavaliker, J N; Chauhan, D S; Sachan, Shailendra; Wasim, Mohammad; Tripathi, Sanjay; Dutt, Nilesh; Jain, Nitin; Joshi, Nalin; Penmesta, Sita Ram Raju; Gaddam, Sumanlatha; Gupta, Sanjay; Khamar, Bakulesh; Dey, Bindu; Mitra, Dipendra K; Arora, Sunil K; Bhaskar, Sangeeta; Rani, Rajni
